FDA nod for Pfizer’s combination therapy for non-small cell cancer
HQ Team October 12, 2023: The Food and Drug Administration has approved Pfizer Inc.’s treatment for metastatic non-small cell lung cancer. The FDA.
Drugs
Health
Pharma